|
Multiple sclerosis
Citations 441-450 of 475 total displayed.
|
Past content
(since Jan 2001):
|
- ARTICLES
A randomized, double-blind, placebo-controlled MRI study of anti–herpes virus therapy in MS
- E. Bech, J. Lycke, P. Gadeberg, H.J. Hansen, C. Malmeström, O. Andersen, T. Christensen, S. Ekholm, S. Haahr, P. Höllsberg, T. Bergström, B. Svennerholm, and J. Jakobsen
Neurology 2002; 58: 31-36.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Prevalence, expenditures, utilization, and payment for persons with MS in insured populations
- G.C. Pope, C.J. Urato, E.D. Kulas, R. Kronick, and T. Gilmer
Neurology 2002; 58: 37-43.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Prevalence estimates for MS in the United States and evidence of an increasing trend for women
- Curtis W. Noonan, Steven J. Kathman, and Mary C. White
Neurology 2002; 58: 136-138.
[Abstract]
[Full text]
[PDF]
- ARTICLES
The effect of IFNß-1b on the evolution of enhancing lesions in secondary progressive MS
- P. A. Brex, P. D. Molyneux, P. Smiddy, F. Barkhof, M. Filippi, T. A. Yousry, D. Hahn, Y. Rolland, O. Salonen, C. Pozzilli, C. H. Polman, A. J. Thompson, L. Kappos, and D. H. Miller
Neurology 2001; 57: 2185-2190.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical–MRI correlations in a European trial of interferon beta-1b in secondary progressive MS
- P. D. Molyneux, G. J. Barker, F. Barkhof, K. Beckmann, F. Dahlke, M. Filippi, M. Ghazi, D. Hahn, D. MacManus, C. Polman, C. Pozzilli, L. Kappos, A. J. Thompson, K. Wagner, T. Yousry, and D. H. Miller
Neurology 2001; 57: 2191-2197.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Paroxysmal dystonia (tonic spasm) in multiple sclerosis
- Emmanuelle Waubant, Paul Alizé, Ayman Tourbah, and Yves Agid
Neurology 2001; 57: 2320-2321.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Final analysis of the European multicenter trial on IFNß-1b in secondary-progressive MS
- L. Kappos, C. Polman, C. Pozzilli, A. Thompson, K. Beckmann, and F. Dahlke
Neurology 2001; 57: 1969-1975.
[Abstract]
[Full text]
[PDF]
- ARTICLES
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis
- C. Fusco, V. Andreone, G. Coppola, V. Luongo, F. Guerini, E. Pace, C. Florio, G. Pirozzi, R. Lanzillo, P. Ferrante, P. Vivo, M. Mini, M. Macrì, G. Orefice, and M. L. Lombardi
Neurology 2001; 57: 1976-1979.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Interferon-ß1b in the treatment of secondary progressive MS: Impact on quality of life
- J. A. Freeman, A. J. Thompson, R. Fitzpatrick, M. Hutchinson, C. Miltenburger, K. Beckmann, F. Dahlke, L. Kappos, C. Polman, and C. Pozzilli
Neurology 2001; 57: 1870-1875.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Surgical therapy for tremor in multiple sclerosis: An evaluation of outcome measures
- J. Matsumoto, D. Morrow, K. Kaufman, D. Davis, J.E. Ahlskog, A. Walker, D. Sneve, J. Noseworthy, and M. Rodriguez
Neurology 2001; 57: 1876-1882.
[Abstract]
[Full text]
[PDF]
|
|
